Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Revenue

Schedule of reportable segment included under sales category

	Three Months Ended September 30, 2021						Three Months Ended September 30, 2020
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	936	$	936	$	—	$	799	$	799
Other		—		329		329		—		300		300
Total		—		1,265		1,265		—		1,099		1,099
Nutritionals —
Pediatric Nutritionals		586		514		1,100		488		518		1,006
Adult Nutritionals		333		675		1,008		330		588		918
Total		919		1,189		2,108		818		1,106		1,924
Diagnostics —
Core Laboratory		291		1,001		1,292		284		892		1,176
Molecular		162		183		345		220		238		458
Point of Care		100		35		135		96		35		131
Rapid Diagnostics		1,394		746		2,140		533		342		875
Total		1,947		1,965		3,912		1,133		1,507		2,640
Medical Devices —
Rhythm Management		266		305		571		242		265		507
Electrophysiology		192		293		485		192		249		441
Heart Failure		170		59		229		144		46		190
Vascular		219		425		644		230		400		630
Structural Heart		177		215		392		159		194		353
Neuromodulation		149		41		190		170		36		206
Diabetes Care		323		798		1,121		226		617		843
Total		1,496		2,136		3,632		1,363		1,807		3,170
Other		6		5		11		15		5		20
Total	$	4,368	$	6,560	$	10,928	$	3,329	$	5,524	$	8,853

Note 3 — Revenue (Continued)

	Nine Months Ended September 30, 2021						Nine Months Ended September 30, 2020
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	2,672	$	2,672	$	—	$	2,376	$	2,376
Other		—		843		843		—		780		780
Total		—		3,515		3,515		—		3,156		3,156
Nutritionals —
Pediatric Nutritionals		1,622		1,637		3,259		1,490		1,629		3,119
Adult Nutritionals		1,006		1,987		2,993		948		1,644		2,592
Total		2,628		3,624		6,252		2,438		3,273		5,711
Diagnostics —
Core Laboratory		845		2,935		3,780		840		2,312		3,152
Molecular		431		651		1,082		429		527		956
Point of Care		289		112		401		278		109		387
Rapid Diagnostics		3,178		2,732		5,910		1,246		719		1,965
Total		4,743		6,430		11,173		2,793		3,667		6,460
Medical Devices —
Rhythm Management		776		881		1,657		655		727		1,382
Electrophysiology		580		823		1,403		476		652		1,128
Heart Failure		483		167		650		411		140		551
Vascular		684		1,292		1,976		628		1,108		1,736
Structural Heart		537		654		1,191		386		508		894
Neuromodulation		460		124		584		392		97		489
Diabetes Care		865		2,292		3,157		614		1,736		2,350
Total		4,385		6,233		10,618		3,562		4,968		8,530
Other		31		18		49		30		20		50
Total	$	11,787	$	19,820	$	31,607	$	8,823	$	15,084	$	23,907

Schedule of changes in contract liabilities

(in millions)
Contract Liabilities:
Balance at December 31, 2020	$	405
Unearned revenue from cash received during the period		416
Revenue recognized related to contract liability balance		(409)
Balance at September 30, 2021	$	412